Pancreatic Neoplasms
317
42
52
142
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
37 trials with published results (12%)
Research Maturity
142 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
29 terminated out of 317 trials
83.0%
-3.5% vs benchmark
5%
17 trials in Phase 3/4
26%
37 of 142 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 142 completed trials
Clinical Trials (317)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
HTL0039732 in Participants With Advanced Solid Tumours
Pancreatic Cancer Detection Consortium
Studies of Blood Glucose and the Microbiome in Tumors and Cysts of the Pancreas
UCSF PANC Cyst Registry
Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers
A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
Real-Time AI During Pancreatoscopy for Detection of Pancreatic Neoplasia
EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer
Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients
Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy
Hepatic Resection for Metastatic Pancreatic Cancer
Wearable-Supported Prehabilitation and Rehabilitation for Patients Undergoing Surgery for Pancreatic Cancer
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD
EUS-DFI in Solid Pancreatic Lesions